Selling a Medical Practice: How Healthcare Buyers Evaluate Value

The physician practice M&A landscape: who is buying and why it determines your process

For adjacent context, compare this with Selling a Precision Machining or Metal Fabrication Business: What Buyers Evaluate and Selling an Electrical or Plumbing Contractor: M&A Issues Unique to Licensed Trades; the strongest operators connect these topics instead of treating them as separate workstreams.

Physician practice acquisitions come from three distinct buyer categories, hospital systems, PE-backed physician management organizations (PMOs), and specialty-specific rollup platforms, and the right buyer depends on the practice's specialty, size, geography, and the physician's goals for post-close involvement. Each buyer type values different attributes, structures deals differently, and has a different relationship with the selling physician after close.

The most important decision a selling physician makes before a process is not which offer to accept, it is which buyer type to approach. A physician who values autonomy and equity upside will be deeply unhappy in a hospital employment model, regardless of purchase price. A physician who wants a guaranteed salary and to stop managing a business may find the PE-backed model misaligned with their expectation of continued independence. Clarifying the post-close life goal before running a process prevents the most common physician seller regret: accepting the highest purchase price without understanding what comes with it.

Selected precedent physician practice transaction markers, 2022-2026

Physician practice multiples are specialty-specific and heavily affected by MSO structure, provider retention, payer mix, Stark and corporate-practice rules, and whether the platform has growth infrastructure. Publicly disclosed transaction-level multiples are limited, so use market datasets carefully.

Source basis: 2025-2026 medical practice valuation research, Taureau 2025 healthcare services data, and Scope Research public-source physician contracting database description.

What moves the multiple

The precedent comps are useful context, but buyers do not pay the same multiple for every business in a sector. They adjust valuation based on evidence that the business can sustain earnings, transfer customer relationships, and keep operating without the founder carrying the system personally.

The practical seller objective is not to argue that the company deserves the highest public comp. It is to prove which risks do not apply, which risks have already been fixed, and which operating strengths justify the buyer moving toward the higher end of the relevant range.

Clinical valuation: wRVUs, procedure mix, and how buyers model physician productivity

In most physician practice acquisitions, revenue is modeled as a function of physician productivity (specifically wRVUs) rather than as a stable, independently generated revenue stream. This is because physician revenue is fundamentally tied to physician time and effort: if the producing physician reduces their clinical schedule, revenue declines proportionally. Buyers model this risk by benchmarking each physician's current wRVU output against national percentiles and projecting revenue sustainability under different physician schedule scenarios.

The MGMA (Medical Group Management Association) and AMGA (American Medical Group Association) publish annual physician compensation and productivity surveys that serve as the primary benchmark source in practice valuations. A physician operating at the 75th percentile of wRVU productivity for their specialty demonstrates above-average clinical intensity that supports the revenue run rate. A physician at the 40th percentile raises questions about capacity utilization, scheduling efficiency, or whether the revenue can be maintained if the physician's schedule changes post-close.

Payer contracts, assignment, and reimbursement risk in physician practice M&A

Physician practice revenue is collected through payer contracts, agreements between the practice (or the individual physicians) and insurance carriers that set reimbursement rates for specific CPT codes. These contracts are not automatically transferable in a sale transaction. Most payer contracts contain change-of-control provisions that require notification to the payer and, in some cases, re-credentialing or re-contracting with the acquiring entity. If a payer contract is not successfully assigned, the practice cannot bill that payer post-close, which could eliminate a significant portion of revenue.

The most common payer-related purchase price adjustment in physician practice M&A: a buyer discovers post-LOI that 2–3 major payer contracts require re-contracting rather than simple assignment, and that the re-contracting process will take 90–180 days post-close. The purchase price is then subject to a holdback or escrow tied to successful re-credentialing, the seller does not receive the full purchase price at close. Sellers who map their payer contract assignment provisions before LOI negotiation can either resolve the issue pre-close or negotiate the holdback structure on informed terms.

Compliance: Stark Law, Anti-Kickback, and what buyers investigate

Healthcare regulatory compliance is the highest-stakes diligence category in physician practice M&A. Unlike a manufacturing company where an environmental finding results in a purchase price adjustment, a Stark Law or Anti-Kickback Statute violation can result in False Claims Act liability, exclusion from Medicare and Medicaid, and criminal exposure, outcomes that void the acquisition thesis entirely. Buyers conduct formal legal compliance reviews, often through outside healthcare counsel, before committing to any physician practice transaction.

The two primary regulatory frameworks governing physician compensation and referrals are the Stark Law (prohibiting physician self-referral to entities with which the physician has a financial relationship, with exceptions) and the Anti-Kickback Statute (prohibiting compensation arrangements intended to induce referrals, with safe harbors). The practical implication for a selling physician: any arrangement where the physician receives compensation from or makes referrals to an entity in which they have an ownership interest must fit within a recognized Stark exception or AKS safe harbor. If it does not, the arrangement must be restructured before a sale process begins.

One pre-sale action that disproportionately de-risks compliance diligence: commission a pre-sale compliance audit from a healthcare attorney or compliance consultant 12–18 months before a process. The cost is typically $15–40K for a mid-size practice. The value is twofold: it identifies and resolves issues while there is time to fix them (rather than during diligence when buyers hold price reduction leverage), and it produces a compliance report that sellers can present to buyers as evidence of a well-run, audit-ready practice. This is one of the highest-ROI pre-sale investments available to physician founders.

Preparing your physician practice for sale: key documentation and timeline

The documentation required in physician practice M&A is more extensive than in most other business types, reflecting the regulatory overlay, payer complexity, and clinical data requirements. Sellers who have this documentation organized before a process move significantly faster through diligence and avoid the most common closing delays.

The physician practice M&A timeline is longer than most founders expect. From initial buyer conversations to close, a well-run process typically takes 6–9 months, longer if payer re-credentialing is required, regulatory approvals are needed, or state-specific CPOM structures require additional legal work. Sellers who engage an advisor 12–18 months before their target close date have time to complete pre-sale compliance work, build out documentation, and run a structured process without timeline pressure.